{"name":"Thiogenesis Therapeutics, Inc.","slug":"thiogenesis-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"D-Mannitol","genericName":"D-Mannitol","slug":"d-mannitol","indication":"Investigational neuroprotective indication (specific indication not publicly disclosed)","status":"phase_2"}]}],"pipeline":[{"name":"D-Mannitol","genericName":"D-Mannitol","slug":"d-mannitol","phase":"phase_2","mechanism":"D-Mannitol is an osmotic agent that draws fluid into the intracellular space to reduce intracranial pressure and improve cellular hydration.","indications":["Investigational neuroprotective indication (specific indication not publicly disclosed)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE9GVnZWc2hSdDlkNzlXckRBdlMxek81UEJBQVhFc3dfdElDclZSbXQ4UThjT3hZbUpxM2VtWWxoUElmQXhxMkVXZ1puQ3RSUHFpQXNPbEVRY3Y0UGUydW0yMENFSFBUZw?oc=5","date":"2026-04-05","type":"pipeline","source":"GuruFocus","summary":"Stock List: Research Stocks from Around the World - GuruFocus","headline":"Stock List: Research Stocks from Around the World","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxONGFpRVkwTTNZMUlaRzFxZWFVSWdhbHdOZGRTTDdVbWhueFNuRWF0X3NEa3ZLc0hzRzBwbHQ4eE1wVWFrMFlxV2NBZUlMeDJkRGJlVXkwWGp2Q2YzUFRpVUk2cXlaMjBhbkpVN2JOcjhWc3lSLWhnRHpBNE5STERPSUpJWVdMdGJ5QUpSTzgtX3NYZjMxeHpLRklvRQ?oc=5","date":"2026-03-19","type":"pipeline","source":"openPR.com","summary":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies - openPR.com","headline":"Acute Respiratory Distress Syndrome Pipeline 2026: Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxQZ3I3S2xEdHVpNms0eS1UdmJrVHVNVDRtUGdIajNQdVlRaVdrLTFUUEpFNXlfMFplNG1iMnVJNHhBV3lxVWhXT0V0RzZBZ0Q3RFVxZWtKcGZ1RUc4NHBCblVNZVFQNDlpWDAzQU9VejZXdEI5VzRXSzVYVmZPcElHU1BHNWxzX09YTm44TEt6X0w4Mk1tTkxwenIzT2NYV3RpbjJBMmVwUURXVFhWY1Jha0hCNGJfRkFneUhtUWMwWW5BbnRiOWxrbUU0WnZpVi1ja0tpZ1BkaTh2amtubmxSUXZlYzMwVU5qVUhoX2JzdGw1LUpQeGh5aml3bFhRZVBJR2JoMV90OFcyVWhDWnc?oc=5","date":"2025-11-04","type":"trial","source":"newsfilecorp.com","summary":"Thiogenesis Reports Positive Interim Phase 2 Trial Results for MELAS and Announces Pipeline Advancements in Leigh Syndrome and Cystinosis - newsfilecorp.com","headline":"Thiogenesis Reports Positive Interim Phase 2 Trial Results for MELAS and Announces Pipeline Advancements in Leigh Syndro","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNanhyaVhmanFEcEZmeFlHNm9qS3R1SFZFTDNYa2NEOXJsVHVSVTBrd1dBZUhHSUZEeExDWXM0T2thbFhIbXlfY2VuNDBXaWlTNUhkRkxCaEc5Q0RoRTFlLTVkQWZMODBlZHJlbU1KVERXN1JfYXR3d0Z3N3otbVZMd1BneTBYQmxrY0VGNzdhMGdwUGlubXh3U2RVeWVFLXJmUnhXbDdLbFVwSFNNNVNhWXJpeGJJZjljSVRFZ3dCVl8ybnNHb21ZOGUydVFZZ1MyRFRxLXVxOHRacE9odEJjQTNreGNXQmJjeDRuWg?oc=5","date":"2025-02-05","type":"pipeline","source":"BioSpace","summary":"Melas Syndrome Market Size to Reach USD 494.2 Million by 2035, Impelled by Increasing Prevalence of Genetic Mutations - BioSpace","headline":"Melas Syndrome Market Size to Reach USD 494.2 Million by 2035, Impelled by Increasing Prevalence of Genetic Mutations","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNVnE1Q0VZN0Y5X19qMVV4VVRQbVRtYURpaGhkTkZWOHMxSHlCWWhwTFM5OU50WEVYXy1lQ3h1MDNVMTZJUHp3LUZRMjYzMF9DdWpNejc0ejJJek5uX0ZlZF9sOG9TNk9LTjFMSjdXaGdFdmRSTno1R1FXUkI5Qm54YTM4NFo1eHN1VFpjNkc4eWZVam9RdVRRa0xZOWpaQUh5NXBKaG0tN1p2N3hiZkgxN1BvTkQ?oc=5","date":"2024-01-05","type":"pipeline","source":"drugdiscoverytrends.com","summary":"Biotech investment diversifies into cell therapies and immunology - drugdiscoverytrends.com","headline":"Biotech investment diversifies into cell therapies and immunology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVEFVX3lxTE1nM3ZUU1A2NkI2ZHViMk9xcy0tMDkzd2h3VzFpcTJqUEYyYlRLZnVZVm9ialZyX3drNWR2NzF6VGtOdTI4MDJtT1JKMG5keEd6RmUwZQ?oc=5","date":"2023-06-20","type":"pipeline","source":"Yahoo! Finance Canada","summary":"ZYUS Life Sciences Corporation (ZYUS.V) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"ZYUS Life Sciences Corporation (ZYUS.V) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}